Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: «FIRMA «SILICEA» LLC 2004-12-01
Seri Bilgileri:Российский кардиологический журнал
Konular:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Online Erişim:https://russjcardiol.elpub.ru/jour/article/view/2326
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller